Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?
about
The macrophage: a therapeutic target in HIV-1 infectionRole of heparan sulfate in sexually transmitted infectionsA new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivoConformational gating of dimannose binding to the antiviral protein cyanovirin revealed from the crystal structure at 1.35 Å resolutionMonomerization of Viral Entry Inhibitor Griffithsin Elucidates the Relationship between Multivalent Binding to Carbohydrates and anti-HIV ActivityHIV-1 gp120 as a therapeutic target: navigating a moving labyrinthNarcissus tazetta lectin shows strong inhibitory effects against respiratory syncytial virus, influenza A (H1N1, H3N2, H5N1) and B virusesPotent host-directed small-molecule inhibitors of myxovirus RNA-dependent RNA-polymerasesHigh mannose-binding lectin with preference for the cluster of alpha1-2-mannose from the green alga Boodlea coacta is a potent entry inhibitor of HIV-1 and influenza viruses.Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N.Surfactant protein D inhibits HIV-1 infection of target cells via interference with gp120-CD4 interaction and modulates pro-inflammatory cytokine production.Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy.Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy.The antiviral protein cyanovirin-N: the current state of its production and applications.Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial.Algal lectins as potential HIV microbicide candidatesSynergistic actions of tailoring enzymes in pradimicin biosynthesis.High mannose-binding antiviral lectin PFL from Pseudomonas fluorescens Pf0-1 promotes cell death of gastric cancer cell MKN28 via interaction with α2-integrinPotential anti-HIV agents from marine resources: an overview.Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin.Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virusEffect of the Crystal Environment on Side-Chain Conformational Dynamics in Cyanovirin-N Investigated through Crystal and Solution Molecular Dynamics Simulations.Crystal structure of MytiLec, a galactose-binding lectin from the mussel Mytilus galloprovincialis with cytotoxicity against certain cancer cell types.A Designed "Nested" Dimer of Cyanovirin-N Increases Antiviral Activity.A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion.Involvement of envelope-glycoprotein glycans in HIV-1 biology and infection.Proteins with antifungal properties and other medicinal applications from plants and mushrooms.HIV sexual transmission and microbicides.Anti-tumor and anti-viral activities of Galanthus nivalis agglutinin (GNA)-related lectins.Recent developments in therapeutic applications of Cyanobacteria.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.NICTABA and UDA, two GlcNAc-binding lectins with unique antiviral activity profiles.Multivalent interactions with gp120 are required for the anti-HIV activity of Cyanovirin.Topology and structural self-organization in folded proteins.Pathobiology of virus glycosylation: implications to disease and prospects for treatmentDifferential Recognition of Mannose-Based Polysaccharides by Tripodal Receptors Based on a Triethylbenzene Scaffold Substituted with Trihydroxybenzoyl MoietiesSpirulina (Arthrospira): An Important Source of Nutritional and Medicinal Compounds
P2860
Q26823236-81699EF4-1452-4292-BDE7-B8D4DE96FC1EQ27023959-5FC3D128-CF84-4FEF-AA1D-8F7B530855C3Q27490484-ECA6A022-4B08-496A-946F-94A79EC687A4Q27650458-D389FD4F-6158-4BC6-8161-8646DF3ED090Q27664363-DA0C6693-5F90-418B-8D4C-E0ABAD136E8FQ28086826-7BC933AB-88C6-4BA4-AA36-F237C0059035Q28280442-83F141A8-C3A4-460A-B654-1FCCE6739E67Q28478155-B99D7468-9F81-4F42-B539-D403907D5499Q30401412-B91AD89E-C8C9-4A62-AC75-3ABFC7C9067FQ30437696-FBAC8670-1842-415B-A287-8439D36BEA66Q33921367-9162069F-BA2E-4243-B8FB-BCFDC9B9B274Q34005185-BA860BFA-5A1D-437F-B5AA-953C72ABE3F8Q34016463-6DAFAE3F-E07A-4512-835F-A322327798F8Q34099268-C4C1DF0A-A4CD-49B2-8F23-549835372E1BQ34231097-E351AE9A-48C0-41F9-830F-4A7E8166CAFDQ34291727-91CE93D4-9704-4844-BF07-914D4CEE9562Q34426609-F929CDC7-1809-4E5D-9288-961FACCAC1D6Q34430396-0E6B6E7F-B0C9-4A3D-BD5C-A85994D16F57Q34576118-AA1971D2-F003-445E-A48E-B0DC702723B6Q34894092-CE83F031-61B3-442F-BC90-F3CC06CDEEBCQ35568986-DAAC2519-E9F9-4BE0-99A9-0A740737A758Q36255912-59D91D2E-C426-4A82-8993-294005151971Q37019297-3C9FD35A-F8DF-416A-B23C-B71550237FD9Q37049964-5526DD4C-7C1D-46D5-9C7C-DE87C8F63631Q37336219-0C087A31-7521-4CBA-B07A-0E372F57DB1CQ37724696-8734B4FE-EEEC-4F9A-9FE4-A0E6E6343207Q37763603-886D5167-34BC-4C6E-B709-EBAC0EB795D0Q37853935-27AE263F-7487-460D-A168-B3029333582FQ38034665-7214C7C4-F047-4BBB-AE35-C46F51BEF1E9Q38335345-AE76B060-66F9-40F1-A1FB-28EFE41E3509Q38866173-995699BA-7D3E-4655-AEFB-BD1F1B978790Q40168596-C5714121-48D8-462B-B83F-A77BB408EF61Q51805853-63B8865E-4ABD-4A53-8E93-9DC59DAB2039Q54601794-E3ACDB73-9964-4355-8492-631535FCF86FQ57202110-38F04E50-9218-4979-BB7E-D041F347873DQ57977629-517398BE-B4DB-45E7-893D-4D013E0D7768Q59015903-D729FF2B-91AE-4A44-801C-2211734CEE8D
P2860
Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Carbohydrate-binding agents: a ...... otherapy of enveloped viruses?
@ast
Carbohydrate-binding agents: a ...... otherapy of enveloped viruses?
@en
type
label
Carbohydrate-binding agents: a ...... otherapy of enveloped viruses?
@ast
Carbohydrate-binding agents: a ...... otherapy of enveloped viruses?
@en
prefLabel
Carbohydrate-binding agents: a ...... otherapy of enveloped viruses?
@ast
Carbohydrate-binding agents: a ...... otherapy of enveloped viruses?
@en
P2860
P1476
Carbohydrate-binding agents: a ...... otherapy of enveloped viruses?
@en
P2093
Jan Balzarini
P2860
P356
10.1177/095632020701800101
P577
2007-01-01T00:00:00Z